Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

India's Eris buys nine dermatology brands from Dr. Reddy's for $33 mln (updated)

(Adds details of the deal, background, share move)
       BENGALURU, March 16 (Reuters) - 
    Indian drugmaker Eris Lifesciences Ltd  ERIS.NS  said on
Thursday it had bought nine dermatology brands from Dr. Reddy's
Laboratories Ltd  REDY.NS  in a 2.75 billion rupees ($33.24
million) deal, to expand in the cosmetic dermatology business.
  
        The deal, to be paid in cash, is expected to be
completed on or before March 31, Eris 
    said
     in a stock exchange filing.
  
        Eris and Dr. Reddy's did not immediately respond to
Reuters' requests seeking the names of the dermatology brands.  
  
        The deal comes two months after Eris 
    said
     it would acquire a portfolio of dermatology brands from
Glenmark Pharmaceuticals Ltd  GLEN.NS  for 3.4 billion rupees to
deepen its presence in the anti-fungal and anti-psoriasis
segments.
  
        Eris' shares were trading 1.4% lower as of 2:33 p.m. IST
and were headed for a sixth straight session of losses. They
have fallen 9.2% since announcing the deal with Glenmark. 
  
        
  
($1 = 82.7250 Indian rupees)

 (Reporting by Yagnoseni Das and Hritam Mukherjee in Bengaluru;
Editing by Rashmi Aich and Eileen Soreng)
 ((Yagnoseni.Das@thomsonreuters.com; +91 6001289066;))

Recent news on Eris Lifesciences

See all news